Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Hiroki Omizo"'
Autor:
Kazuhiro Sakai, Hiroki Omizo, Ryo Togashi, Yuto Hayama, Masaki Ueno, Yoshihiro Tomomitsu, Yoshikazu Nemoto, Shinichiro Asakawa, Michito Nagura, Shigeyuki Arai, Osamu Yamazaki, Yoshifuru Tamura, Shunya Uchida, Shigeru Shibata, Yoshihide Fujigaki
Publikováno v:
Renal Replacement Therapy, Vol 6, Iss 1, Pp 1-8 (2020)
Abstract Background Rhabdomyolysis may develop into acute kidney injury (AKI), a life-threatening complication. Obese people are at risk for rhabdomyolysis due to prolonged immobilization. However, there are only a few reports of rhabdomyolysis-induc
Externí odkaz:
https://doaj.org/article/5f4408afa3914a12bf5d7dc24fcf5685
Autor:
Minoru Yasukawa, Hiroki Omizo, Kazuhiro Sakai, Sachiko Kitagawa, Takahiro Kikuyama, Masaki Yamanaka, Fumika Ochiai, Ryo Togashi, Yoshikazu Nemoto, Tatsuya Ota, Hideyuki Kawashima, Shintaro Takamura, Yusuke Watanabe, Ken Kozuma, Shigeru Shibata, Yoshihide Fujigaki
Publikováno v:
Renal Replacement Therapy, Vol 5, Iss 1, Pp 1-6 (2019)
Abstract Background Transcatheter aortic valve implantation (TAVI) has evolved to be a treatment of choice in high-risk patients with aortic stenosis (AS). However, it is not known whether TAVI is safe and beneficial for the creation of arteriovenous
Externí odkaz:
https://doaj.org/article/ffac752e652a4520a0564d93251d4417
Autor:
Wen Xiu Chang, Ning Xu, Takanori Kumagai, Takeshi Shiraishi, Takahiro Kikuyama, Hiroki Omizo, Kazuhiro Sakai, Shigeyuki Arai, Yoshifuru Tamura, Tatsuru Ota, Shigeru Shibata, Yoshihide Fujigaki, Zhong Yang Shen, Shunya Uchida
Publikováno v:
PLoS ONE, Vol 11, Iss 4, p e0154469 (2016)
Although hyperphosphatemia is deemed a risk factor of the progression of chronic kidney disease (CKD), it remains unclear whether the normal range of serum phosphorus likewise deteriorates CKD. A propensity score analysis was applied to examine the c
Externí odkaz:
https://doaj.org/article/201bdb2f0f874ca1a94f6709b4f4fac2
Autor:
Yoshihide Fujigaki, Shunya Uchida, Hiroki Omizo, Kazuhiro Sakai, Shigeru Shibata, Yoshifuru Tamura, Yoshikazu Nemoto, Ryo Togashi, Osamu Yamazaki, Masaki Ueno, Shinichiro Asakawa, Michito Nagura, Yuto Hayama, Shigeyuki Arai, Yoshihiro Tomomitsu
Publikováno v:
Renal Replacement Therapy, Vol 6, Iss 1, Pp 1-8 (2020)
BackgroundRhabdomyolysis may develop into acute kidney injury (AKI), a life-threatening complication. Obese people are at risk for rhabdomyolysis due to prolonged immobilization. However, there are only a few reports of rhabdomyolysis-induced AKI due
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4a5d14e00014c0adf8f0867561f116a5
http://link.springer.com/article/10.1186/s41100-020-00277-w
http://link.springer.com/article/10.1186/s41100-020-00277-w
Autor:
Shunya Uchida, Emiko Kuribayashi-Okuma, Yuto Hayama, Hiroki Omizo, Yoshifuru Tamura, Shigeru Shibata, Chikayuki Morimoto, Masaki Ueno
Publikováno v:
Scientific Reports, Vol 10, Iss 1, Pp 1-10 (2020)
Scientific Reports
Scientific Reports
Although hyperuricemia has been shown to be associated with the progression of cardiovascular disorder and chronic kidney disease (CKD), there is conflicting evidence as to whether xanthine oxidase (XO) inhibitors confer organ protection besides lowe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cb4c9224ce652e2b3b7f8a3583dfdc19
http://link.springer.com/article/10.1038/s41598-020-65706-6
http://link.springer.com/article/10.1038/s41598-020-65706-6
Autor:
Yoshihide Fujigaki, Ryo Togashi, Takahiro Kikuyama, Hiroki Omizo, Ken Kozuma, Shigeru Shibata, Tatsuya Ota, Yoshikazu Nemoto, Minoru Yasukawa, Masaki Yamanaka, Hideyuki Kawashima, Sachiko Kitagawa, Shintaro Takamura, Fumika Ochiai, Kazuhiro Sakai, Yusuke Watanabe
Publikováno v:
Renal Replacement Therapy, Vol 5, Iss 1, Pp 1-6 (2019)
BackgroundTranscatheter aortic valve implantation (TAVI) has evolved to be a treatment of choice in high-risk patients with aortic stenosis (AS). However, it is not known whether TAVI is safe and beneficial for the creation of arteriovenous fistula f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0e4925e5fac5ec705d19d1a0910ac418
https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85084388708&origin=inward
https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85084388708&origin=inward
Autor:
Yutaka Miura, Kazuhiro Sakai, Kenichi Ishizawa, Hiroki Omizo, Hiroshi Kawachi, Takanori Kumagai, Shigeru Shibata, Yoshikazu Nemoto, Takeshi Shiraishi, Chikayuki Morimoto, Yoshihide Fujigaki, Osamu Yamazaki, Makoto Kuro-o, Yoshifuru Tamura, Shunya Uchida
Publikováno v:
Scientific Reports
Scientific Reports, Vol 9, Iss 1, Pp 1-11 (2019)
Scientific Reports, Vol 9, Iss 1, Pp 1-11 (2019)
Recent clinical studies indicate that the disturbed phosphate metabolism in chronic kidney disease (CKD) may facilitate kidney injury; nonetheless, the causal role of phosphate in CKD progression remains to be elucidated. Here, we show that intestina
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3fc23d2b8424be6df9a7e7a82c28c83a
http://europepmc.org/articles/PMC6370755
http://europepmc.org/articles/PMC6370755
Autor:
Takanori Kumagai, Kazuhiro Sakai, Zhong Yang Shen, Ning Xu, Shunya Uchida, Wen Xiu Chang, Takeshi Shiraishi, Takahiro Kikuyama, Hiroki Omizo, Shigeyuki Arai, Yoshifuru Tamura, Tatsuru Ota, Yoshihide Fujigaki, Shigeru Shibata
Publikováno v:
PLoS ONE
PLoS ONE, Vol 11, Iss 4, p e0154469 (2016)
PLoS ONE, Vol 11, Iss 4, p e0154469 (2016)
Background Although hyperphosphatemia is deemed a risk factor of the progression of chronic kidney disease (CKD), it remains unclear whether the normal range of serum phosphorus likewise deteriorates CKD. A propensity score analysis was applied to ex
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::12028a76977bf0892f8f14bbef92886e
http://europepmc.org/articles/PMC4849666
http://europepmc.org/articles/PMC4849666